Obsessive Compulsive Disorder (OCD)

Pipeline Programs↗

Active Trials↗

Companies Involved↗

Obsessive Compulsive Disorder (OCD) is an early-stage landscape with 0 programs across 1 company. The most active players are Novartis.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

71/100

Attrition Rate

22/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved

Phase 3

Phase 2

Phase 1

Preclinical

Key Players

Top Companies

Novartis

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

clinical trials

Completed5 · 56%

Terminated2 · 22%

Unknown status1 · 11%

Recruiting1 · 11%

Clinical Trials

Trial Activity

9 trials

Connectomic Deep Brain Stimulation for Obsessive Compulsive Disorder

Recruiting·IIcahn School of Medicine at Mount Sinai·Preclinical·NCT05160129·22 enrolled

Efficacy of Adding Topiramate to Current Treatment in Refractory Obsessive Compulsive Disorder (OCD)

Completed·MMcMaster University·Phase 4·NCT00182520·23 enrolled

Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)

Completed·MMassachusetts General Hospital·Phase 4·NCT00116532·30 enrolled

N-methyl Glycine (Sarcosine) for the Treatment of Obsessive Compulsive Disorder (OCD)

Completed·—·Phase 2·NCT01031927·30 enrolled

Ondansetron in Treatment Resistant Obsessive Compulsive Disorder (OCD)

Completed·—·Phase 4·NCT00796497·14 enrolled

Duloxetine for the Treatment of Obsessive Compulsive Disorder (OCD)

Completed·MMassachusetts General Hospital·Phase 4·NCT00464698·20 enrolled

Study of NPL-2003 in Adolescents With Obsessive Compulsive Disorder (OCD)

Terminated·NNeuropharm·Phase 2·NCT00515255·6 enrolled

Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy

Terminated· Novartis logo

Novartis·Phase 2·NCT01813019·50 enrolled

Cost-Effectiveness of Adding Web-Based Cognitive-Behavioral Therapy (CBT) to Luvox CR for Obsessive Compulsive Disorder (OCD)

Unknown status·RRogers Center for Research & Training, Inc.·Phase 4·NCT00743834·50 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)